ESTRO37_ProgrammeBook

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

ELECTRONIC POSTERS

> Oligoprogression during Abiraterone therapy treated with radiotherapy in mCRPC patients L. Marinelli, C. Reverberi, L. Nicosia, S. Magrini, S. Giacinti, G. Poti, G. Arrivi, M. Osti, V. De Sanctis, C. Proietti, A. Aschelter, P. Marchetti, M. Valeriani (Italy) > Decision support for rectum spacers: combining tumor control, rectum toxicity and genetic markers Y. VanWijk (The Netherlands), B. Vanneste, A. Jochems, S. Walsh, P. Lambin > Pre-treatment mpMRI accuracy and prognostic value in intermediate risk localized prostate cancer D. Büchser (Spain), A. Gómez-Iturriaga, F. Casquero, A. Urresola, A. Ezquerro, J. Cacicedo, I. San Miguel, F. Suarez, P. Bilbao > Comparison of prostate delineation on multi-modality imaging for MR-guided radiotherapy A. Pathmanathan (United Kingdom), M. Schmidt, D. Brand, L. Delacroix, C. Eccles, A. Gordon, T. Herbert, H. McNair, N. Van As, R. Huddart, A. Tree > Inter-observer contouring variation of multiple pelvic structures on CT and MR for prostate cancer D. Roach (Australia), M.A. Ebert, M. Jameson, J.A. Dowling, A. Kennedy, P. Greer, L. Holloway > Tri-modalities for bladder cancer in elderly: TUR, hypofractionated radiotherapy and gemcitabine H. Hamza Abbas (Egypt), M. Salem, A. Gbre, M. Engaar > Outcomes Following Primary Radiochemotherapy in Patients with Localy Advanced Bladder Cancer I. Albitskiy (Israel), T. Aro, T. Charas, G. Amiel, R. Ben Yosef > Development and evaluation of a MRI based delineation guideline for renal cell carcinoma F.M. Prins (The Netherlands), L.G.W. Kerkmeijer, J.R.N. Voort van Zyp, W.S.C. Eppinga, H.D. Heerkens, J.J.W. Lagendijk, R.H.N. Tijssen, E.P.A. Vonken, A.N.T.J. Kotte, M.M. Barendrecht, W. Chu, M.P.W. Intven

EP-1610

EP-1611

EP-1612

EP-1613

EP-1614

ELECTRONIC POSTER Clinical track: Urology-non-prostate

EP-1615

EP-1616

EP-1617

Programme and Exhibition Guide | POSTERS AND ELECTRONIC POSTERS

303